Trademark: 98083674
Word
ENZEEVU
Status Date
Wednesday, April 10, 2024
Filing Date
Thursday, July 13, 2023
Published for Opposition
Tuesday, May 14, 2024
5 pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure
Jul 17, 2023
New Application Entered
Aug 13, 2023
New Application Office Supplied Data Entered
Mar 21, 2024
Assigned To Examiner
Mar 22, 2024
Non-Final Action Written
Jan 3, 2024
Automatic Update Of Assignment Of Ownership
Mar 22, 2024
Non-Final Action E-Mailed
Mar 22, 2024
Notification Of Non-Final Action E-Mailed
Apr 5, 2024
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 5, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 5, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 5, 2024
Teas Change Of Correspondence Received
Apr 5, 2024
Teas Change Of Owner Address Received
Apr 5, 2024
Teas Change Of Domestic Representatives Address
Apr 5, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 8, 2024
Teas/Email Correspondence Entered
Apr 8, 2024
Correspondence Received In Law Office
Apr 8, 2024
Teas Response To Office Action Received
Apr 9, 2024
Approved For Pub - Principal Register
Apr 24, 2024
Notification Of Notice Of Publication E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
